The Role of Anti-Thymocyte Globulin (ATG) in Patients with AML Transplanted in CR1 from Sibling and Unrelated Donors with or without Measurable Residual Disease (MRD) at the Time of Allogeneic Stem Cell Transplantation:a Study on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) - UTU Research Portal

A1 Refereed original research article in a scientific journal

The Role of Anti-Thymocyte Globulin (ATG) in Patients with AML Transplanted in CR1 from Sibling and Unrelated Donors with or without Measurable Residual Disease (MRD) at the Time of Allogeneic Stem Cell Transplantation:a Study on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Authors: Arnon Nagler, Myriam Labopin, Gerard Socié, Anne Huynh, Maija Itälä-Remes, Eric Deconinck,Ibrahim Yakoub-Agha,
Jean-Yves Cahn, Jean Henri Bourhis, Hélène Labussière-Wallet,Sylvain Chantepie, Jordi Esteve, Mohamad Mohty

Publisher: Kluge Carden Jennings Pub. Co.

Publication year: 2019

Journal: Biology of Blood and Marrow Transplantation

eISSN: 1523-6536

DOI: https://doi.org/10.1016/j.bbmt.2018.12.126

Web address : 10.1016/j.bbmt.2018.12.126